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Abstract The objective of this descriptive study is to explore
the relationships between pain, sleep disturbance, and quality
of life among Palestinian patients diagnosed with cancer in the
West Bank. A cross-sectional, descriptive-correlational design
was used to collect data from 184 patients with cancer. The
quality of life questionnaire, visual analogue pain scale, and
physical health status were used in data collection. The results
showed that the mean score for pain was 5, the best function-
ing was for cognitive scale (M=75, SD=29), the worst symp-
toms experienced by patients was appetite loss (M=47, SD=
35), a moderate global health status (M=53, SD=27), and the
mean for sleep disturbance was 43 (SD=35). Pain and sleep
disturbance showed high negative correlations with functional
scales of quality of life and positive with symptom scales. The
findings showed that the co-occurrence of pain and sleep dis-
turbance was negatively correlated with quality of life (QoL)
and positively with symptom scales. The regression analysis
revealed that pain and sleep disturbance accounted for a sig-
nificant proportion of variance in the QoL (p<0.001), and the
highest proportion was in predicting global health status
(41.9 %). The findings of this study give evidence about the
importance of assessing pain and sleep quality among Pales-
tinian patients with cancer.
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Introduction
Cancer is a leading cause of death worldwide. Globally, it
causes 8.2 million deaths every year, accounting for 13 % of
all deaths [1]. Lung, stomach, colon, breast, and prostate can-
cer are the most common types of cancer worldwide [2]. In
spite of increasing incidence of cancer, there are evidences
that survival rate is improving in the last few years that might
be related to advancement in cancer treatment and related
preventive and health promotion services [3]. Studies report
that by the year 2050, there will be a further 40 % increase in
the number of people living with cancer [3]. Cancer is a mul-
tifaceted disease that has serious consequences on individual’s
physical and psychosocial life [1]. Patients with cancer suffer
a number of physical and psychological disturbances such as
pain, depression, and sleep problems that negatively affect
their way of living and perception of their lives [1]. The steady
improvement in survival rate for cancer, however, highlighted
the importance of holistic and integrated health-care services
to manage the physical and psychosocial deterioration in pa-
tients’ health. Thus, health professionals and researchers were
concerned lately about the impact of cancer on patients’ qual-
ity of life (QoL) as indicators of integrated care services [4].
Further, health-care professionals had also signified the factors
that may influence QoL of patients diagnosed with cancer
giving the facts that long survival with cancer requires under-
standing of the biopsychosocial aspect of health and well-
being [4]. The treatment process of those patients whether
for cure or to enhance their survival may distort their lives
further [4]. Treatment plans that aim at adding more years to
patients’ lives may interfere with their ability to manage their
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life appropriately, resulting in further deterioration and low
perception of their QoL [5]. Thus, patients’ QoL is compro-
mised as a result of the disease process or treatment plans [4].
Patients with cancer are subject to a number of health prob-
lems that are physical and psychological in nature [6]. Studies
showed that disturbed sleep and high levels of pain were com-
mon among patients with cancer [7]. The significance of these
problems is mainly related to its profound impact on patient’s
physical, physiological, emotional, social, and spiritual well-
being that, consequently, deteriorates patients’ QoL [8]. Pain
has been reported as one significant psychological element
that is an inevitable concern and a problem that patients with
cancer are suffering on a daily base [7]. About 30 % of pa-
tients with cancer are suffering pain at the time of diagnosis,
and this rate increases to 90% as the disease progresses due to
consequences of the tumor process making pain due to cancer
systematic, pervasive, and enduring [7, 9]. The association of
pain and its consequences on the physical and psychological
stability of patients has been established in the literature, and
showed significant association with low perception of QoL [7,
8, 10]. Maio and colleagues [11] reported that 50% of patients
diagnosed with cancer in their study reported that pain affect-
ed their daily activities and decreased their mean global QoL
from 65 to 36.5 %. Such report infers that pain is one signif-
icant factor influencing QoL and functional ability among
patients with cancer. Thus, pain is one significant component
that needs to be assessed and controlled throughout the health-
care process. Another factor that may interfere with QoL
among patients with cancer is sleeping problems. Studies
showed that sleep disturbances are common among patients
diagnosed with lung and breast cancer [12]. Nocturnal
sleeping and daytime wakefulness were found to be very im-
portant for health and functioning for patients with cancer
[13]. Sleep disturbance has negative impact on the physical,
cognitive performance, and motor function of individuals di-
agnosed with cancer [14]. Cancer and its treatment modalities
affect the quality of sleep leading to low mood, cognitive
function that are assumed to compromise patients’ QoL [15].
Vena and colleagues [16] found that patients with lung cancer
had more disturbances in nocturnal sleep compared to healthy
adults, and that sleep disturbances associated with poor QoL.
The World Health Organization [1] reported that the
Eastern Mediterranean Region is witnessing a growing
incidence of cancer in the coming 15 years. The figures
are considered alarming to those interested in improving
care to patients diagnosed with cancer. In Palestine, can-
cer is the second leading cause of death among those at
age of 20–59 [17]. The Palestinian and regional litera-
ture reports that cancer incidence is increasing, and
mortality rates seem significant especially among wom-
en [4, 5, 17]. The treatment of cancer such as chemo-
therapy and radiotherapy may compromise QoL for pa-
t ients [5]. Pat ients with cancer are subject to
deteriorations in physical and psychological health status
such as pain and sleep disturbance that may deteriorate
patients’ ability to manage and function normally
[8–10]. Previous studies showed that such physical and
psychological symptoms will jeopardize patients’
functionability, causing negative impact on their QoL
[7, 9]. This calls professionals caring for patients with
cancer to adopt and integrate a model of care that re-
quires more attention to patients’ QoL and its correlated
factors. Palestine, unlike other countries of the work due
to political restrains, suffers a dearth of knowledge and
information related to such correlates. Although other
studies in the regions have been found to address such
issue [18], this study could be among the rare ones that
addressed the bio-psychological factors of Palestinian
patients diagnosed with cancer. In the region, a number
of studies had emphasized the psychosocial wellbeing of
patients with chronic illnesses neglecting those diag-
nosed with cancer [18–20]. The study expands our
knowledge about the interrelationship among these fac-
tors within the Palestinian context. Therefore, the pur-
pose of this study was to explore the relationships be-
tween pain, sleep disturbance, and QoL among Palestin-
ian patients diagnosed with cancer in The West Bank,
Palestine. The study is also emphasizing the effect of
specific demographic characteristics on patients’ percep-
tion of their QoLs and assessing prediction power of
pain and sleep disturbance on quality of life among
the patients.
Methods
Design
The study utilized a cross-sectional, descriptive-correlational
design. Data was elicited from the participants using a self-
reported questionnaires format. The study utilized well-
established, reliable, and valid measures.
Sample and Settings
All Palestinian patients diagnosed with cancer represent-
ed the population of this study. A convenience sampling
technique was used to recruit the subjects. Potential
participants were all patients who were admitted to the
oncology units or to the day care of the selected health
institutions with confirmed medical diagnosis of the first
five types of cancer that are lung, breast, stomach, co-
lon, and prostate cancer. The literature focused either on
one type of cancer or the general types of cancer. Fur-
thermore, these types of cancer were recruited in order
to make comparison across demographic, clinical, pain,
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sleep disturbance, and QoL variables. Inclusion criteria
were (1) aged 18 years or older, (2) able to read and
write Arabic, and (3) who is undergoing or receiving
chemotherapy. The patients were excluded if they (1)
have comorbid diseases such as lung, heart, or any
chronic diseases as they could affect the perceived
QoL for patients with cancer; (2) have a history of a
second primary tumor; and (3) are receiving medications
for pain or sleep disturbance as they could affect the
participant’s response regarding them. The two health-
care centers, in the West Bank, that mainly provide care
to patients with cancer were targeted to be representa-
tive of the sample. The first center is in the south, and
the second one is in the north of the West Bank. The
two centers are governmental hospitals and provide che-
motherapy and surgeries as modalities for the manage-
ment of patients with cancer. Human participants’ right
to confidentiality, privacy, and safety were securely
protected throughout the project. Prior to data collec-
tion, ethical approval was obtained from the targeted
institutions.
Measures: the Study Used the Following Measures
1. The Visual Analogue Pain Scale (VAS) [21] was used to
measure pain. It is an instrument that measures the amount of
pain that a patient feels and ranges across a continuum from
none to an extreme amount of pain. The VAS is a 100-mm
horizontal line, with two anchors at the left and right end; the
anchor of the left end is marked by no pain, and the right
anchor is the worst pain imaginable. Each participant was
asked to assign a number on this line from 0 to 10 correspond-
ing to the pain intensity that he/she feels at the moment. The
VAS is a reliable and well-validated measure of pain intensity
in patients with cancer [22].
2. The European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire-C30 (EORTC-C30) was
established to measure QoL in patients with cancer [23]. In
this study, the EORTC-C30 version-3 scale was used to mea-
sure QoL. The EORTC-C30 is a cancer-specific tool with 30
items which were designed to assess health functions, individ-
ual symptoms, and global health status. Patients were asked to
respond to each item of the EORTC-C30 on a Likert-type
scale ranging from 1 to 4 except the last two items which
ranges from 1 to 7. The range of the EORTC-C30 scores is
between 0 and 100. A high score for the functional subscale
represents a high level of functioning, a high score for the
global health status represents high QoL, but a high score
for a symptom scale represents a high level of symptomatol-
ogy. The EORTC-C30 is a highly validated and reliable mea-
sure [24]. The Arabic version of EORTC-C30 was used in this
study, and the Cronbach’s alpha for all dimensions of
EORTC-C30 were above 0.65.
3. The NottinghamHealth Profile (NHP) was used to measure
subjective physical, emotional, and social aspects of health
[25]. Part I of the survey measures six dimensions of health
including physical mobility, pain, social isolation, emotional
reactions, energy, and sleep. Between three and eight items are
associated with each dimension. Part II of the survey consists
of Yes/No statements about seven areas of life that are most
affected by health status [25]. For the purpose of this study,
sleep items of the NHPwas used tomeasure sleep disturbance.
Scores range from 0 to 100. A higher score indicates a poor
sleep [25].
Data Collection Procedure
Prior to data collection, ethical approval was obtained from
the targeted institutions. Head of institutions and research co-
ordinators facilitated approaching subjects and invited them to
the study. Those who expressed interest in participation were
approached by the researcher who explained the study, pur-
poses, its significance, and what is expected from them. The
eligible participants were asked to read the cover letter. The
cover letter included information about the purpose of the
study, its significance, confidentiality of their responses, and
a statement that they can withdraw at any time without any
consequences. Data collection was conducted during patients’
visits to the health center, and prior to their chemotherapy
sessions. Participants were instructed that their completion
of the questionnaires will be considered as an approval to
participate. Finally, the researcher reviewed the participants’
medical records to extract the required information after their
approval.
Data Analysis
Data was analyzed using Statistical Package for Social Sci-
ences (SPSS) software program version 19. Alpha was set at
0.05. Descriptive statistics were used to characterize the sam-
ple, pain, sleep disturbance, and measures of QoL. Regarding
inferential statistics, Pearson’s r correlation was used to mea-
sure the correlation among pain, sleep disturbance, and QoL. t
test and ANOVAwere used to assess the differences in demo-
graphic and clinical characteristics regarding the QoL. Finally,
multiple linear regressions were used to examine sleep distur-
bance and pain in the prediction of QoL.
Results
Patient Characteristics
As shown in Table 1, female participants were 56.5 %
(n=104) compared with males 43.5 % (n=80) among
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the 184 participants. The average age of patients was
53.5±15.2, 71.2 % (n=131) of them were married,
and 70.1 % (n=129) had completed high school or less.
Only 17.4 % (n=32) were full-time employed compared
with 65.2 % (n=120) who were unemployed. The me-
dian for duration of diagnosis was 6 months. Forty-eight
percent (n=88) of the sample were recruited from the
northern hospital and 52 % (n=96) from the southern
hospital (Table 1).
Pain
As shown in Table 2, the mean score for pain among patients
with cancer measured by VAS was 5 (SD=2.8). The scoring
varies from 0 to 10. The range for the participants was 10.
There were 25 % (n=46) with a score less than 3 and 75 %
(n=138) less than 7. This indicated that majority of the par-
ticipants had moderate pain or less.
Quality of Life
In relation to QoL, the analysis showed that the best function-
ing was for cognitive scale (M=75, SD=29) with scores rang-
ing from 0 to 100 and the worst one was for physical func-
tioning (M=60, SD=31). The analysis showed that 50 % (n=
92) of the patients had a score of 83 or above, indicating that
most patients had a high cognitive functioning. On the other
hand, 50 % (n=92) of the patients had a score of 67 or less,
indicating that many patients experience low to moderate
physical functioning. The symptom scales also showed that
the worst symptoms experienced by patients with cancer was
appetite loss (M=47, SD=35). The analysis showed that 50 %
(n=92) of the patients had a score of 33 or above, indicating
that most of the patients experienced loss of appetite. The best
(lowest) one of the symptoms was diarrhea (M=26, SD=33)
as 75 % of the sample (n=145) had a score of 33 or less, and
this indicates that the least symptom experienced by patients
with cancer was diarrhea. The results showed a moderate
global health status (M=53, SD=27). Regarding sleep distur-
bance, the mean was 43 (SD=35). There are 50 % who had a
score of 40 or above; this indicates that many patients had a
sleep disturbance. The majority of the participants
(64.1 %, n=118) woke up in the early morning, and
33.7 % (n=62) were taking pills to get sleep. Moreover,
there are 42.4 % (n=78) who stated that they lie awake
for most of the night (Table 3).
Table 1 Demographic characteristics of the sample (n=184)
Variable Number Percent M SD P50 Min Max
Age (years) – – 53.5 15.2 55.0 20.0 83.0
Gender
Male 80 43.5 – – – – –
Female 104 56.5
Marital status
Single 26 14.2 – – – – –
Married 131 71.2
Divorced 10 5.4
Widow 17 9.2
Level of education
High school or less 129 70.1 – – – – –
Diploma 21 11.4
Baccalaureate 30 16.3
Graduate 4 2.2
Working status
Unemployed 120 65.2 – – – – –
Full-time job 32 17.4
Part-time job 13 7.1
Retired 19 10.3
Type of cancer
Lung 35 19.0
Breast 44 24.0 – – – – –
Colon 40 21.7
Prostate 33 18.0
Stomach 32 17.3
Duration of diagnosis
(months)
– – 9 8 6 1 36
Hospitals
North 88 48
South 96 52
Table 2 Descriptive characteristics of the pain, sleep disturbance and
quality of life functional scales, global health status, and symptom scales
(n=184)
Variable M SD Range P25 P75
Pain 5.0 2.8 10 3.0 7.0
Sleep disturbance 43.0 34.6 100 12.6 77.6
Functional scales
Physical functioning 60.0 31.0 100 33.0 87.0
Role functioning 65.0 31.0 100 50.0 100
Emotional functioning 67.0 27.0 100 50.0 92.0
Cognitive functioning 75.0 29.0 100 50.0 100
Social functioning 65.0 31.0 100 33.0 100
Global health status 53.0 27.0 100 33.0 73.0
Symptom scales
Fatigue 45.0 29.0 100 22.0 67.0
Nausea and vomiting 37.0 33.0 100 0.0 67.0
Pain 42.0 27.0 100 17.0 67.0
Dyspnea 35.0 36.0 100 0.0 67.0
Insomnia 45.0 35.0 100 33.0 67.0
Appetite loss 47.0 35.0 100 33.0 67.0
Constipation 31.0 35.0 100 0.0 67.0
Diarrhea 26.0 33.0 100 0.0 33.0
Financial difficulties 41.0 57.0 100 0.0 67.0
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Bivariate Analysis
Regarding gender differences, t test was used to assess the
differences between males and females. The analysis showed
significant differences between males and females regarding
QoL, and pain. Statistically significant differences were found
in four scales, pain (t=−2.38, p=0.018), cognitive functioning
(t=3.69, p<0.001), social functioning (t=2.26, p=0.025), and
financial difficulties (t=−2.44, p=0.016) with higher scores
(more problems) for females across these scales. There were
no statistically significant differences between the two hospi-
tals across all variables (p>0.05). Regarding types of cancer,
one-way ANOVAwas conducted; it was found that there were
only statistically significant differences in nausea and
vomiting (F=2.94, p=0.022), dyspnea (F=5.56, p<0.001),
appetite loss (F=5.17, p=0.001), and marginally constipation
(F=2.43, p=0.049). Post hoc analysis showed that lung can-
cer has the majority of these differences. Further analysis
showed that there were no differences between types of cancer
across other variables. Moreover, there were no significant
differences between duration of diagnosis and types of cancer
(F=2.263, p=0.064). Pearson’s correlation was used to exam-
ine the correlations among pain, sleep disturbance, period of
diagnosis, and QoL dimensions. As shown in Table 4, pain
showed high negative correlations with physical functioning
(r=−0.490, p<0.001) and global health status (r=−0.632,
p<0.001). Sleep disturbance also showed high negative cor-
relations with emotional functioning (r=−0.509, p<0.001)
and positively correlated with loss of appetite (r=0.508,
p<0.001). A statistically significant correlation between pain
and sleep disturbance also existed (r=0.448, p<0.001). Re-
garding the period of diagnosis, there were no significant cor-
relations between period of diagnosis, pain, and sleep distur-
bance (p>0.05). On the other side, there were significant cor-
relations between period of diagnosis and physical function-
ing (r=−0.23), emotional functioning (r=−0.19), and global
health status (r=−0.17). All relationships were negative cor-
relations, indicating that the more period of diagnosis, the
lower the physical, emotional, and global health status
(Table 4). Regression analysis was performed to examine the
contribution of pain and sleep disturbance in QoL. A two-step
multiple hierarchical regression analysis was performed. The
demographic variables were entered in the first model and
pain and sleep disturbance in the second model. The results
showed that the demographic variables accounted for a signif-
icant proportion of variance across most of the functional,
symptom scales of the QoL and global health status
(p<0.05). The results also showed that there was a significant
inverse relationship when pain and sleep disturbance were
regressed on QoL. The highest prediction was for global
health status (42.6 %) and the lowest one was for diarrhea
(6.2 %). In general, all models were significant (all p<0.05)
across all subscales of QoL except diarrhea. The results of
regression were summarized in Table 5. The results implies
that an increase in pain and sleep disturbance were associated
with a decrease in all functional scales and global health status
of QoL and associated with an increase in symptom scales
(Table 5).
Discussion
Patients with cancer tend to experience more and more signs
and symptoms by time during the trajectory of the disease due
to cancer or its treatment. The results of this study showed that
a significant proportion of Palestinian patients with cancer
have moderate pain, sleep disturbance, and QoL. As expected,
there were no differences between the two settings regarding
pain, sleep disturbance, or QoL. This could be due to the fact
that both of them are governmental hospitals and caring for
similar patients with cancer. The results of the current study
regarding pain is corresponding with the literature that pain is
one significant psychological problem among patients with
cancer [26]. Pain is affected by many factors such as stage
of disease, therapeutic modalities (i.e., chemotherapy, radio-
therapy, or surgery), duration of diagnosis, and metastasis.
The score of pain in this study varied across participants re-
garding the severity of pain. One possible explanation is that
patients in this study varied in the period of diagnosis, sever-
ity, and methods of treatment that might have interfered with
their level of reported pain. However, the wide range of dura-
tion of diagnosis leads to an average of moderate pain per-
ceived by Palestinian patients with cancer. The results support
previous works that high numbers of patients with cancer
suffer from pain [27]. The differences between males and
females in their reports of pain correspond with previous stud-
ies [26]. This may be attributed to the fact that females are
more emotional and experienced signs and symptoms of the
disease in a more intense way than males [28]. There were
above 40 % of the sample who reported that they experienced
problems in getting to sleep, lie awake most of the night, bad
sleep at night, and waking up in the early morning. These
results showed that sleep disturbance is a significant problem
among patients with cancer. It was correlated positively with
Table 3 Descriptive characteristics of sleep disturbance for participants
who responded yes to each question (n=184)
Items Frequency Percentage
1. I take pills to help me sleep. 62 33.7
2. I’m waking up in the early hours of the
morning.
118 64.1
3. I lie awake for most of the night. 78 42.4
4. It takes me a long time to get to sleep. 81 44.0
5. I sleep badly at night. 74 40.2
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pain and symptom scales and negatively with functional
scales of QoL and global health status. These results were
consistent with previous researches [15]. Lin and colleagues
[29] explored the common symptom among patients with lung
cancer and found that 93 % complain from sleep disturbance.
The discrepancies in the results could be due to the differences
in the sample as Lin and colleagues had selected patients with
lung cancer who had accepted surgical treatment. From the
other side in this study, the top five types of cancer were
included which may be responsible for this variety in the fre-
quency of sleep disturbances. The results of this study show
that the sample had a relatively moderate level of overall QoL.
The moderate level of functional and symptom scales may be
explained by the adverse effects of the disease symptoms on
the patients or the treatment modalities. Patients with cancer
tend to have better cognitive functioning than physical, social,
emotional, and role functioning. Most of the patients with
cancer suffer from appetite loss. On the other side, the least
symptoms experienced by them were diarrhea and constipa-
tion. These results were consistent with other studies [30, 31].
Alacacioglu et al. [30] found that patients with lung cancer
hadmoderate QoLwithmeans ranged from 9 to 72; the lowest
one was diarrhea, and the highest one was for cognitive func-
tioning. There were approximately the same results also in the
Safaee et al. [32] study which assessed the QoL for patients
with breast cancer. They found that the mean ranged from 4 to
72 for diarrhea and cognitive functioning, respectively. How-
ever, in another study, QoL was found to be low on all aspects;
most of the dimensions of QoL were less than half of full
function, and more severe symptoms were found [24]. The
possible explanations for that were due to the sample charac-
teristics; for example, the differences in duration of diagnosis,
stage of cancer, presence of comorbidities and surgeries, and
inclusion of more than one type of cancer could lead to this
variability. Despite the differences in the types of cancer,
many studies had found almost the same results regarding
the symptom scales [33]. The present study found that pain
was correlated positively with symptom scales and negatively
with global health status and functional scales of QoL. Pain
affected patients with cancer at all levels. Besides, pain in-
creases the negative symptoms experienced by patients with
cancer. This may be either related to tumor burden or to dif-
ferent treatment modalities. These findings were consistent
with other studies [34]. Maio and colleagues [11] found that
pain in patients with cancer correlated significantly with QoL,
and high levels of pain correlated with low QoL while mild or
low pain correlatedwith highQoL. It was also found that there
was a reduction in the global QoL in patients with severe pain
compared with patients who are free of pain. In another study,
Table 4 Intercorrelations among pain, sleep disturbance, and quality of
life subscales (n=184)
Variable Pain Sleep disturbance Period of diagnosis
Functional scales
PF −0.49a −0.47 a −0.23a
RF −0.32a −0.48a −0.12
EF −0.42a −0.51a −0.19b
CF −0.34a −0.37a −0.11
SF −0.28a −0.37a −0.06
GHS −0.63a −0.43a −0.17b
Symptom scales
FA 0.45a 0.52a 0.24a
NV 0.38a 0.41a 0.18b
PA 0.48a 0.49a 0.19a
DY 0.33a 0.34a 0.18b
SL 0.39a 0.61a 0.17b
AP 0.35a 0.51a 0.15b
CO 0.26a 0.30a 0.01
DI 0.21a 0.21a 0.08
FI 0.23a 0.24a 0.14
PF physical functioning, RF role functioning, EF emotional functioning,
CF cognitive functioning, SF social functioning, GHS global health sta-
tus, FA fatigue, NV nausea and vomiting, PA pain, DY dyspnea, SL in-
somnia, AP appetite loss, CO constipation, DI diarrhea, FI financial
difficulties
a Correlation is significant at the 0.01 level (2-tailed)
b Correlation is significant at the 0.05 level (2-tailed)
Table 5 Multiple hierarchical regressions to predict dimensions of
quality of life from pain and sleep disturbance (n=184)
Variables Pain SD
β t value β t value
PF −3.898 −5.078** −0.281 −4.591**
RF −1.403 −1.723** −0.380 −5.868**
EF −2.341 −3.433** −0.315 −5.807**
CF −2.239 −2.854** −0.226 −3.600**
SF −1.695 −1.954** −0.268 −3.888**
GHS −5.369 −8.751** −0.140 −2.860**
FA 2.768 3.918** 0.333 5.913**
NV 2.954 3.295** 0.294 4.118**
PA 3.194 4.774** 0.268 5.034**
DY 2.974 3.004** 0.239 3.032**
SL 1.868 2.235* 0.557 8.374**
AP 1.993 2.225* 0.441 6.183**
CO 2.042 1.929 0.248 2.938**
DI 1.795 1.838 0.139 1.785
FI 1.881 1.953 0.163 2.131*
SD sleep disturbance, PF physical functioning, RF role functioning, EF
emotional functioning, CF cognitive functioning, SF social functioning,
GHS global health status, FA fatigue, NV nausea and vomiting, PA pain,
DY dyspnea, SL insomnia,AP appetite loss,CO constipation,DI diarrhea,
FI financial difficulties
*p<0.05; **p<0.01
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Fujimura et al. [35] found that pain was related with a poor
QoL score. There were also other studies that found more than
40 % of their samples to suffer from pain [36, 37]. The results
also showed that there were significant correlations between
period of diagnosis and QoL dimensions. The more the period
of diagnosis, the less the functioning scales and the more the
symptoms experienced by patients with cancer. This is con-
sistent with a previous study [5]. On the other side, these
results were contradictory with some studies as in Phipps
et al. [38] who found that there were no significant correla-
tions between period of diagnosis and QoL dimensions. How-
ever, this incongruity could be due to the sample characteris-
tics as they recruited long-term colon cancer survivors. In
relation to the general population norms, Costa-Requena and
Gil [39] found that there were no significant differences be-
tween patients with cancer and the general population regard-
ing QoL domains.
In consistent with the literature [27, 34], the results of the
regression analysis showed that pain and sleep disturbance
accounted for a significant proportion of variance in the
QoL. The predictions were positive in symptom scales and
negatively with functional scales and global health status. This
study supports the premise that perceived pain and sleep dis-
turbance lead to impairment across dimensions of QoL. These
results support the previous work of Pud [27] who found pain
as a significant predictor for QoL in patients with cancer.
The limitations in the current study are inclusion of more
than one type of cancer. However, assessing many types of
cancer allows for making comparisons among them. The de-
scriptive design prevents assessment of causality. Although
data collection was based on valid and reliable instruments,
it is based on subjective reports of the quantity of the variables
of the study. This may lead to overestimation or underestima-
tion of these variables.
Conclusion
The findings of this study showed that the co-occurrence of
pain and sleep disturbance was negatively correlated with
QoL and positively with symptom scales. Furthermore, fe-
male participants seem to experience more pain and sleep
disturbance than male participants. Patients with lung cancer
tend to experience more symptoms in intense ways compared
with other types of cancer. These findings offered an evidence
for health-care workers to include these variables in symptom
assessment and to provide assistance and care for patients with
cancer who had such symptoms.
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